Full text is available at the source.
How the body’s clock gene Bmal1 relates to tumor growth and cancer drug response
Updated
Abstract
Knockdown of the Bmal1 gene accelerated tumour growth in mice.
- Down-regulation of Bmal1 gene expression increased cell proliferation in laboratory settings.
- Suppressing Bmal1 expression in colon cancer and fibroblast cells decreased cell death caused by anti-cancer drugs.
- Bmal1 deficiency led to altered levels of several key proteins involved in cell cycle regulation, including increased cdc2 and cyclins.
- Loss of Bmal1 reduced the expression of genes associated with apoptosis and cell cycle control.
- Bmal1 may influence the development of tumours and the effectiveness of anti-cancer treatments.
Simplified